Sanofi gets USFDA breakthrough therapy designation for hemophilia A drug Efanesoctocog alfa Ruchika Sharma2 Jun 2022 5:03 PM ISTHemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.
Women more likely to develop skin rash from Moderna COVID vaccine: Japanese study Ruchika Sharma2 Jun 2022 4:13 PM ISTThe symptoms were mild and not considered a contraindication of the mRNA-based vaccine, according to the June 1 report in the Journal of the American...
TG Therapeutics lymphatic cancer treatment Ukoniq no longer authorised by USFDA Ruchika Sharma2 Jun 2022 3:55 PM ISTThe U.S. health regulator said based on updated clinical trial data it has determined that the risks of treatment with Ukoniq outweigh its benefits.
MedTech startup EzeRx raises undisclosed amount as seed funding from Mankind Pharma promoters Ruchika Sharma2 Jun 2022 3:29 PM ISTThe fund raised will be used for scaling up its operations and marketing along with boosting its sales in various markets across India, Africa, and...
Pfizer plans to exit 32 percent stake in GSK JV Haleon after demerger Ruchika Sharma2 Jun 2022 1:14 PM ISTBefore the spinoff, the holding company for Haleon will pay dividends to GSK and Pfizer. GSK said it would receive cash proceeds of more than 7...
Medtronic India unveils Pipeline Vantage Embolization Device with shield technology to treat Brain Aneurysms Ruchika Sharma2 Jun 2022 12:39 PM ISTCerebral or brain aneurysm is a condition where there is a ballooning or weakening of the inside wall of an artery in brain.
Sanofi India names Preeti Futnani as new General Manager for vaccines Ruchika Sharma2 Jun 2022 11:57 AM ISTFutnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India.
Pfizer-BioNTech COVID booster authorized in Canada for 16, 17-year-olds Ruchika Sharma2 Jun 2022 10:00 AM ISTThe agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot's label.
Regrow Biosciences bags USFDA nod for phase II trial of orphan drug Ossgrow in US Ruchika Sharma1 Jun 2022 4:05 PM ISTOsteonecrosis, mainly seen in the hip joint, is a progressive bone disease that leads to the death of bone tissue due to interrupted blood supply.
Natco Pharma partner Viatris to launch first generic version of Nexavar tablets in US Ruchika Sharma1 Jun 2022 2:42 PM ISTSorafenib is prescribed for treatment of unresectable Hepatocellular Carcinoma (HCC), advanced Renal Cell Carcinoma (RCC) and Differentiated Thyroid...
Supreme Court ends Pharmacy Council of India ban on opening new Pharmacy Colleges Ruchika Sharma1 Jun 2022 1:19 PM ISTNew Delhi: In a major move the apex court has overturned the moratorium that was placed by the Pharmacy Council of India on the opening of new...
GSK to purchase Affinivax for USD 3.3 Billion Ruchika Sharma1 Jun 2022 11:30 AM ISTLondon: GSK plc has announced that the company has entered into a definitive agreement to acquire Affinivax, Inc., a clinical-stage biopharmaceutical...
